South Korea Updates Medical Device Change Management Rules: What Manufacturers Need to Know

The regulatory landscape for medical devices in South Korea continues to evolve, with recent updates introducing a more flexible and structured approach to managing product changes.

In March 2026, the Ministry of Food and Drug Safety proposed revisions to the Enforcement Rule of the Medical Devices Act, aiming to streamline how manufacturers handle post-approval changes to medical devices.

This development reflects South Korea’s broader effort to enhance regulatory efficiency while maintaining strong oversight of product safety and performance.

A New Approach to Change Management

One of the most notable updates is the introduction of a “negative list” system for medical device changes.

Under this approach:

• Only changes that significantly impact safety or performance will require prior regulatory approval.

• Other changes can be managed internally by manufacturers, based on their approved quality systems.

This represents a shift from a more rigid approval model to a risk-based regulatory framework, aligning South Korea with international best practices.

What Types of Changes Require Approval?

According to the proposed revisions, prior approval will still be required for changes that may affect:

• Intended use of the device

• Mechanism of action

• Materials or design

• Manufacturing processes or sites

For lower-risk modifications, manufacturers may implement changes without prior approval, provided they follow their internal procedures and maintain proper documentation.

Why This Matters for Medical Device Manufacturers

This update introduces several important implications for companies operating in South Korea.

1. Increased Flexibility

Manufacturers will be able to manage certain changes more efficiently without waiting for regulatory approval, reducing administrative burden.

2. Faster Product Lifecycle Management

The ability to implement low-risk changes internally can help accelerate product updates and innovation.

3. Greater Responsibility on Manufacturers

With increased flexibility comes greater responsibility. Companies must ensure robust internal quality systems and documentation to demonstrate compliance.

Part of a Broader Regulatory Evolution

This update is part of a wider trend in South Korea’s regulatory framework.

Recent developments from the Ministry of Food and Drug Safety also include:

• Updated Good Manufacturing Practice (GMP) regulations in February 2026, strengthening inspection expectations and lifecycle compliance

• New classification rules and definitions aligned with international standards

• Increased focus on software and AI-based medical devices

Together, these changes highlight South Korea’s shift toward a modern, risk-based, and innovation-friendly regulatory system.

Strategic Considerations for Manufacturers

To adapt to these changes, companies should:

• Review and strengthen their internal change management procedures.

• Ensure alignment with MFDS expectations for documentation and compliance.

• Train regulatory and quality teams on the new requirements.

• Monitor further updates as the proposed revisions are finalised.

Proactive preparation will be key to leveraging the benefits of increased flexibility while maintaining compliance.

South Korea’s Direction: Efficiency with Accountability

South Korea is positioning itself as a leading regulatory environment for innovation, balancing faster processes with strong oversight.

By introducing more flexible change-management rules, the regulator is enabling manufacturers to respond more quickly to market needs while ensuring that patient safety remains a priority.

How ARQon Can Support

At ARQon International Group, we support medical device companies navigating evolving regulatory environments across Asia, including South Korea.

Our services include:

• Regulatory strategy and submission support

• Change management and lifecycle compliance

• Regulatory intelligence and monitoring

• Market entry strategies across the Asia-Pacific

As regulatory systems continue to evolve, having the right partner ensures efficient, compliant, and successful market access.